학술논문

Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study
Document Type
Article
Source
In: Journal of the European Academy of Dermatology and Venereology. (Journal of the European Academy of Dermatology and Venereology, October 2023, 37(10):2047-2055)
Subject
Language
English
ISSN
14683083
09269959